S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer

NCT00134095 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: irinotecan hydrochloride
DRUG: tegafur-gimeracil-oteracil potassium
PROCEDURE: adjuvant therapy
PROCEDURE: conventional surgery
PROCEDURE: neoadjuvant therapy

Sponsor

Fukushima Medical University Hospital